The Information Machine

Google DeepMind AI Co-Clinician Launch · history

Version 6

2026-05-02 05:31 UTC · 215 items

Narrative

The Google DeepMind AI co-clinician story has entered a fourth phase defined by OpenEvidence's emergence as a deeply capitalized and architecturally distinct rival, a same-day competitive announcement from Microsoft, and the arrival of granular financial data that transforms the 'product war' framing from commentary into documented market structure. The most significant new financial data: OpenEvidence reached a $12 billion valuation by January 2026[1] having previously raised $210 million at a $3.5 billion valuation[2] and simultaneously launched DeepConsult — marketed as 'the first AI agent purpose-built for physicians.'[2] With 1 million physician-AI clinical consultations documented in a single 24-hour period[3], a named physician-agent product, and a valuation substantially exceeding any other named clinical AI competitor, OpenEvidence is no longer simply the fastest-growing clinical AI platform; it is the best-funded and most scaled competitor in the specific consultation territory DeepMind's co-clinician targets.

New documentation has clarified both the competitive and contextual landscape. A January 2026 Stanford-Harvard State of Clinical AI report[4] provides an institutional baseline assessment of the clinical AI boom, contextualizing the co-clinician's April 2026 launch as arriving at the documented peak of a multi-year growth curve rather than pioneering a new category. Abridge deepened its clinical content strategy beyond NEJM and JAMA with an additional partnership with UpToDate[5], adding one of the most widely used point-of-care clinical reference tools to its embedded EHR decision support layer and making the scribe-to-consultation expansion more architecturally concrete than previously documented. The Included Health partnership was further confirmed via a LinkedIn post from Google DeepMind researcher Joëlle Barral[6]. Critically, on April 30, 2026 — the exact same day as DeepMind's co-clinician announcement — Microsoft published a global healthcare AI transformation report[7] and Amazon formally introduced the Amazon One Medical Health AI assistant[8], concentrating competitive press coverage on a single date and fragmenting the distinctive narrative attention the co-clinician announcement might otherwise have commanded.

Social media amplification continued through May 2, 2026, spreading to YouTube Shorts[9], the r/medicalschool subreddit[10], and additional X/Twitter accounts including physician Derya Unutmaz MD amplifying Alan Karthikesalingam's deep-dive analysis[11]. The r/medicalschool discussion introduces a new demographic: medical students, not practicing physicians, engaging with the co-clinician concept — a community whose professional career will substantially overlap with the system's expected deployment window. The EU AI Act compliance angle has been reframed by at least one industry voice as a 'competitive edge' rather than a compliance burden[12], inverting the prior regulatory-risk framing and suggesting early EU compliance investment may be positioned by some actors as market differentiation.

The competitive map for clinical consultation AI can now be drawn with financial and architectural specificity: OpenEvidence at a $12B valuation[1] with 1M consultations in 24 hours[3] and a dedicated physician agent product[2]; Abridge expanding from documentation to evidence-backed consultation support with NEJM, JAMA, and UpToDate integrations[13][5]; Amazon scaling consumer health AI to all US customers[14][15]; Microsoft publishing global healthcare AI transformation reports on the same day as DeepMind[7]; and Epic integrating native AI charting[16] — all against a backdrop of a Stanford-Harvard institutional report documenting the sector boom[4]. DeepMind's co-clinician remains the most architecturally documented and clinically benchmarked of these systems, and the Included Health randomized trial[6] is the only initiative explicitly designed to generate the kind of randomized outcome evidence JAMA identified as the 2026 evidentiary threshold — a design advantage that may be the co-clinician's most durable competitive differentiator, but one that will not produce results on a timeline competitive with OpenEvidence's current deployment scale.

Timeline

  • 2024-02: Hindustan Times reports Google DeepMind is working on an AI model to help diagnose patients, providing early public evidence the co-clinician initiative was in development at least two years before announcement. [125]
  • 2024-12-05: FDA finalizes recommendations simplifying the approval process for AI-enabled medical devices, providing a forming regulatory pathway for clinical AI systems in the US. [61]
  • 2025-04-11: Harvard Petrie-Flom Center publishes analysis arguing AI and big data are redefining informed consent rules in ways existing frameworks have not yet accommodated. [89]
  • 2026-01: Stanford-Harvard State of Clinical AI report published, providing an institutional baseline assessment of the clinical AI boom and contextualizing the subsequent co-clinician launch as arriving at the documented peak of a multi-year growth curve. [4]
  • 2026-01-22: OpenEvidence doubles its valuation to $12 billion as physician adoption accelerates, establishing it as the highest-valued named competitor in the clinical consultation AI space. [1]
  • 2026-02-06: Epic releases native AI charting for integrated clinical documentation, entering the ambient documentation market as an EHR incumbent. [16]
  • 2026-02-20: Stanford Law School's CodeX publishes analysis arguing that existing healthcare AI disclosure frameworks — including the Mello framework — fail on their own terms when applied to AI in clinical care. [88]
  • 2026-02-27: AMA publishes National Advocacy Update and releases 2026 Physician Survey on Augmented Intelligence showing physician AI use doubled from 2023 to 2026; AMA position: physicians must lead AI tool development. [46][47][48][49][50]
  • 2026-03-10: OpenEvidence announces that AI collaborated with physicians in one million clinical consultations within 24 hours; Amazon launches its healthcare AI assistant on its website and app on the same date. [31][3][15]
  • 2026-04: OpenEvidence raises $210 million at a $3.5 billion valuation and launches DeepConsult, described as 'the first AI agent purpose-built for physicians,' marking a direct product-layer competition with DeepMind's co-clinician architecture. [2]
  • 2026-04: Abridge partners with NEJM, JAMA, and UpToDate for AI clinical decision-making and evidence integration, expanding from AI scribe into evidence-backed clinical decision support embedded in the EHR workflow. [37][13][38][39][40][41][42][43][5][44]
  • 2026-04: MedGemma 1.5 technical report published on arXiv and detailed on Google Research blog, documenting capabilities including 3D medical imaging interpretation and medical speech-to-text (MedASR). [28][126][127][128][129][29][130][131][132]
  • 2026-04-30: Google DeepMind publishes AI co-clinician blog post announcing a research initiative built on a 'triadic care' model, a dual-agent (Planner + Talker) architecture, and benchmark results from 98 primary care scenarios and 140-area consultation skill assessment. [17][26][30][133]
  • 2026-04-30: On the same day as the co-clinician announcement, Microsoft publishes a global healthcare AI transformation report and Amazon introduces the Amazon One Medical Health AI assistant, fragmenting healthcare AI news coverage across four simultaneous major announcements. [52][8][7]
  • 2026-04-30: DeepMind VP Research Pushmeet Kohli, health AI leader Alan Karthikesalingam, Google Research VP Avinatan Hassidim, and Google DeepMind researcher Joëlle Barral separately publish LinkedIn posts amplifying the initiative and confirming the Included Health partnership. [18][19][20][21][6]
  • 2026-04-30: Simultaneous social media amplification across X/Twitter, LinkedIn, and Reddit; Grok (xAI) publicly comments on demo; discussion spreads to r/whitecoatinvestor and r/OpenAI communities. [110][134][135][136][137][138][139][140][141][142][143][144][145][146][147][148][149][150][151][152]
  • 2026-04: Google announces strategic partnership with Included Health for a nationwide randomized study of AI in virtual care, confirmed by multiple sources including Joëlle Barral's LinkedIn post. [22][23][112][25][113][153][6]
  • 2026-05-01: Social media amplification continues globally; YouTube Shorts coverage begins; r/medicalschool Reddit discussion emerges as the first documented medical student engagement with the co-clinician; physician Derya Unutmaz MD amplifies Alan Karthikesalingam's deep-dive analysis on X. [9][90][91][11][30][101][92][93][94][95][10][96][133]
  • 2026-05: AMA publishes updated survey data showing more than 80% of physicians now use AI professionally, establishing mainstream physician AI adoption as the backdrop for the co-clinician's clinical trial phase. [51]
  • 2026-08: (Upcoming) EU AI Act compliance deadline for medtech companies, including AI systems used as safety components in medical devices or direct patient-facing clinical roles — a binding regulatory forcing function for any clinical AI seeking EU market access. [80][82]

Perspectives

Google DeepMind / Google Research

Measured optimism with concrete deployment action: presents AI co-clinician as a research initiative with strong benchmark results, explicitly notes limitations, frames AI as operating under physician authority. The Included Health partnership (confirmed by Joëlle Barral), MedGemma 1.5 technical report, and MedASR documentation signal active transition from research publication to structured clinical validation.

Evolution: reinforced: Joëlle Barral's LinkedIn post adds a named Google DeepMind researcher confirming the Included Health partnership; Google Research blog documenting MedGemma 1.5's 3D imaging and speech-to-text capabilities provides additional technical transparency beyond the arXiv report

[17][18][19][20][21][22][23][24][25][26][27][28][29][6][30]

OpenEvidence

Dominant scaled competitor: a $12B valuation as of January 2026, 1 million physician-AI consultations in a single 24-hour period, $210M in funding, and the launch of DeepConsult — 'the first AI agent purpose-built for physicians' — make OpenEvidence the most capitalized and deployed rival in the clinical consultation AI space DeepMind targets.

Evolution: significantly upgraded: previously documented as a named competitor with a scale milestone; now documented with specific valuation ($12B), funding history ($210M at $3.5B), and a named product (DeepConsult) that directly mirrors the co-clinician's physician-agent architecture

[31][32][1][2][33][34][3][35][36]

Abridge

Systematically expanding from AI scribe to evidence-backed clinical decision support: NEJM and JAMA integrations are now joined by a UpToDate partnership, adding one of the most widely used point-of-care clinical references. Abridge's strategy is to embed clinical evidence directly into the EHR workflow, competing for institutional medical content authority rather than consumer physician adoption.

Evolution: deepened: UpToDate partnership adds a major clinical reference database to the NEJM/JAMA integration already documented; Abridge's expansion into decision support is now confirmed across multiple independent trade sources

[37][13][38][39][40][41][42][43][5][44]

JAMA / medical journal establishment

Institutionally engaged with the evidentiary question and now commercially embedded in clinical AI deployment: JAMA framed 2026 as potentially 'the year of real-world evidence that AI can actually improve patient outcomes,' and Abridge's partnerships with NEJM, JAMA, and UpToDate make medical journals active commercial participants in clinical AI rather than just external validators.

Evolution: reinforced: multiple independent sources documenting the Abridge/NEJM/JAMA/UpToDate partnerships confirm medical journals are now commercial partners in clinical AI deployment, deepening their active role beyond editorial endorsement

[37][45][13][38][39][40][41][42][43][5]

American Medical Association (AMA)

Institutionally supportive of physician-led AI adoption: updated 2026 survey documents that more than 80% of physicians use AI professionally. AMA's explicit position is that physicians must lead in developing AI tools.

Evolution: consistent: 80%+ figure established in prior synthesis; no new AMA developments in current items

[46][47][48][49][50][51]

Microsoft

Competing in healthcare AI at global scale: published a healthcare AI transformation report on April 30, 2026 — the same day as DeepMind's co-clinician announcement — documenting AI progress for patients and medical professionals worldwide, and maintains Epic co-integration for AI solutions embedded in the EHR.

Evolution: new development: Microsoft's same-day April 30 healthcare AI announcement adds a fourth major tech company making simultaneous public healthcare AI claims alongside DeepMind, Amazon, and Epic — creating a crowded news environment on launch day

[52][53][7]

Amazon / Epic (incumbent tech and EHR competitors)

Amazon has formally introduced the Amazon One Medical Health AI assistant and scaled a health AI assistant to all US customers; Epic released native AI charting in February 2026 for integrated clinical documentation. Neither has publicly responded to the co-clinician announcement specifically.

Evolution: updated: Amazon One Medical Health AI assistant launch is now formally documented via Facebook post and Reuters coverage; Epic's February 2026 native AI charting release adds a specific product and date to the EHR competitive front

[54][55][56][57][58][8][59][14][15][16]

FDA (US regulatory)

Moving toward streamlined AI medical device approval: December 2024 finalization of simplified approval recommendations signals a forming regulatory pathway for clinical AI. The FDA's SaMD and AI-enabled device frameworks remain the applicable regime but have not been applied to conversational diagnostic AI specifically.

Evolution: consistent: no new FDA developments in current items

[60][61][62][63][64][65]

EU regulatory and legal analysts (Osborne Clarke, Educo Life Sciences, FPF, DPO Consulting, artificialintelligenceact.eu)

Compliance-focused with a concrete August 2026 deadline: EU AI Act Annex III high-risk classification applies to patient-facing clinical AI. At least one industry voice now frames early EU compliance as a 'competitive edge' rather than a burden, signaling a nascent market-differentiation argument for proactive compliance investment.

Evolution: nuanced: August 2026 deadline framing is now supplemented by an industry 'competitive edge' perspective on EU compliance, suggesting a shift from pure regulatory risk framing toward strategic compliance positioning

[66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][12]

Legal and bioethics scholars (Stanford Law CodeX, Harvard Petrie-Flom Center)

Critically constructive: Stanford Law argues existing disclosure frameworks fail on their own terms; Harvard Petrie-Flom Center argues AI and big data are redefining informed consent rules in ways existing frameworks have not accommodated.

Evolution: consistent: no new legal/bioethics developments in current items

[83][84][85][86][87][88][89]

Medical student community (r/medicalschool)

Newly engaged: the r/medicalschool Reddit discussion represents the first documented medical student response to the co-clinician, from a demographic whose professional careers will substantially overlap with the system's expected operational deployment window.

Evolution: new voice: previously physician communities (LinkedIn, r/whitecoatinvestor) were the documented clinical professional audience; r/medicalschool adds a trainee perspective whose long-term adoption orientation may differ meaningfully from practicing physician early adopters

[10]

Physician community (individual practitioners, LinkedIn, X/Twitter)

Early-adopter enthusiasm backed by majority adoption data: physician Derya Unutmaz MD amplified Alan Karthikesalingam's deep-dive analysis on X; the AMA's 80%+ adoption figure establishes that individual physician voices engaging publicly are representative of a mainstream professional orientation, not an outlier.

Evolution: reinforced: physician Derya Unutmaz MD's amplification adds a named clinical voice; YouTube Shorts coverage signals expansion to video-format clinical commentary

[9][90][91][11][92][93][94][95][96][97][98][99][100][51]

Global multilingual social media amplifiers

Broadly enthusiastic; amplify headline benchmark numbers and the 'AI teammate not AI replacement' framing across multiple languages and platforms including Arabic, Japanese, Chinese, Portuguese, and Spanish.

Evolution: continuing: Arabic-language post joins prior multilingual amplification; YouTube Shorts extends the format to video commentary

[9][90][91][11][30][101][92][93][94]

AI medical scribe market (AWS HealthScribe, Nuance DAX, Freed, DeepCura, Clinically AI)

A mature, distinct market for documentation assistance AI operates in a separate category from diagnostic consultation AI, but Abridge's UpToDate partnership deepens its cross-over into evidence-backed decision support, blurring the category boundary.

Evolution: consistent with deepening: the structural bifurcation between scribe and consultation AI documented in prior synthesis holds; Abridge's UpToDate partnership is the primary evolution, further eroding the categorical separation

[102][103][104][105][106][107][108][109][5]

Tensions

  • Benchmark performance vs. real-world clinical safety: the AI co-clinician achieved strong scores in controlled simulations but underperformed physicians specifically in identifying red flags and guiding physical examinations — the safety-critical skills most consequential in actual clinical settings. [17][110][111]
  • Research trial vs. deployed scale: DeepMind's co-clinician is in the research-to-trial transition with the Included Health nationwide randomized study, while OpenEvidence has documented 1 million physician-AI clinical consultations in a single 24-hour period and reached a $12 billion valuation — creating a scale and capital gap that the randomized trial design cannot close in the near term. [17][112][25][113][31][1][2][3][6]
  • US vs. EU regulatory gap with a concrete deadline: FDA is moving toward simplified AI medical device approval but has not applied its framework to conversational diagnostic AI; the EU AI Act's August 2026 compliance deadline for medtech companies is now specifically documented, creating a near-term forcing function Google has not publicly addressed for either jurisdiction. [114][115][116][117][118][80][82][61][62][63][64][12]
  • Patient transparency and consent: triadic care assumes patient awareness of AI involvement, but Stanford Law argues existing disclosure frameworks fail on their own terms, Harvard Petrie-Flom Center argues AI is redefining consent rules in ways frameworks have not yet accommodated, and the EU AI Act's August 2026 deadline adds mandatory transparency obligations for high-risk AI that may independently mandate disclosure. [119][120][121][83][84][85][86][87][88][73][89]
  • Competitive differentiation in a converging market: the clinical AI market is splitting between scribe/documentation tools and diagnostic/consultation AI, but Abridge's NEJM, JAMA, and UpToDate partnerships are deepening its cross-over into consultation territory, while OpenEvidence's DeepConsult directly mirrors DeepMind's physician-agent architecture with superior scale. DeepMind has not articulated what architecturally or clinically distinguishes the co-clinician from either competitor. [54][55][56][57][58][122][102][103][105][106][108][109][31][37][2][5]
  • Physician leadership vs. industry-led AI deployment: the AMA's position that 'physicians must lead in developing AI tools' sits in tension with a model where major tech companies (Google, Amazon, Microsoft, Epic) design the architecture, benchmarks, and deployment partnerships — with 80%+ physician AI adoption now mainstream, the question of who controls the design of these tools becomes more consequential. [46][47][50][17][24][51][52][7]
  • 'AI teammate' vs. 'AI doctor' branding: multiple social commentators analyze DeepMind's choice of 'co-clinician' over 'AI doctor' as a deliberate framing decision — raising the question of whether the naming obscures rather than resolves the autonomy questions at stake, particularly as OpenEvidence's DeepConsult operates at 1M-consultation scale without the same framing caution. [98][99][123][100][124][31][2]
  • 2026 as evidentiary inflection year: JAMA framed 2026 as potentially 'the year of real-world evidence that AI can actually improve patient outcomes,' but the randomized trial evidence needed (including DeepMind's Included Health study) is still enrolling, while OpenEvidence's 1M-consultation milestone represents scale without randomized outcome evidence. The Stanford-Harvard State of Clinical AI report documents the sector boom without resolving which evidentiary standard — scale or rigor — constitutes proof. [31][37][45][25][4][6]
  • Same-day competitive narrative fragmentation: Microsoft's global healthcare AI report and Amazon's One Medical Health AI assistant launch both appeared on April 30, 2026 — the same day as DeepMind's co-clinician announcement — raising the question of whether DeepMind can establish distinctive narrative ownership in an environment where every major tech company is simultaneously announcing healthcare AI progress. [52][8][7][17][26]

Sources

  1. [1] OpenEvidence Doubles Valuation to $12bn as Physician Adoption Accelerates — reactive:deepmind-ai-co-clinician
  2. [2] OpenEvidence, the Fastest-Growing Application for Physicians in History, Announces $210 Million Round at $3.5 Billion Valuation: OpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians | OpenEvidence — reactive:deepmind-ai-co-clinician
  3. [3] OpenEvidence Achieves Historic Milestone: 1 Million Clinical ... — reactive:deepmind-ai-co-clinician
  4. [4] Clinical AI Has Boomed. A New Stanford-Harvard State of Clinical AI ... — reactive:deepmind-ai-co-clinician
  5. [5] Abridge expands CDS with UpToDate, new content integrations — reactive:deepmind-ai-co-clinician
  6. [6] In partnership with Included Health, we will be launching a first-of-its ... — reactive:deepmind-ai-co-clinician
  7. [7] AI Transformation Accelerates Progress in Healthcare Services for ... — reactive:deepmind-ai-co-clinician
  8. [8] Today, we're excited to introduce the new Amazon One Medical ... — reactive:deepmind-ai-co-clinician
  9. [9] Google DeepMind Launches AI Co-Clinician - YouTube — reactive:deepmind-ai-co-clinician
  10. [10] Google DeepMind AI co-clinician : r/medicalschool - Reddit — reactive:deepmind-ai-co-clinician
  11. [11] Alan takes a deep dive into this remarkable new AI co-clinician from Google DeepMind. — reactive:deepmind-ai-co-clinician (2026-05-01)
  12. [12] The EU AI Act in Healthcare: From compliance to competitive edge — reactive:deepmind-ai-co-clinician
  13. [13] Abridge Integrates Peer-Reviewed Evidence with NEJM & JAMA — reactive:deepmind-ai-co-clinician
  14. [14] Amazon's move to get out ahead in health AI agent race — reactive:deepmind-ai-co-clinician
  15. [15] Amazon launches healthcare AI assistant on its website, app - Reuters — reactive:deepmind-ai-co-clinician
  16. [16] Epic Releases Native AI Charting for Integrated Clinical ... - HLTH — reactive:deepmind-ai-co-clinician
  17. [17] Enabling a new model for healthcare with AI co-clinician — DeepMind Blog (2026-04-30)
  18. [18] researching the path toward AI-augmented care | Pushmeet Kohli — reactive:deepmind-ai-co-clinician
  19. [19] Google DeepMind AI coscientist system validated by lab experiments | Alan Karthikesalingam MD PhD posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  20. [20] Google Research Collaborates with DeepMind on Multi-Agent ... — reactive:deepmind-ai-co-clinician
  21. [21] Dr. Vivek Natarajan, Research Scientist at Google DeepMind/Health ... — reactive:deepmind-ai-co-clinician
  22. [22] Today, Google is announcing a strategic partnership with Included Health to collaborate on a nationwide randomized study of AI in virtual care. AI systems capable of clinical reasoning and dialogue… | Mike Schäkermann | 19 comments — reactive:deepmind-ai-co-clinician
  23. [23] Google Partnership to Pilot New Offering in Outpatient Care Setting | TechTarget — reactive:deepmind-ai-co-clinician
  24. [24] Enabling physician-centered oversight for AMIE - Google Research — reactive:deepmind-ai-co-clinician
  25. [25] Collaborating on a nationwide randomized study of AI in real-world virtual care — reactive:deepmind-ai-co-clinician
  26. [26] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  27. [27] Health AI — Google AI — reactive:deepmind-ai-co-clinician
  28. [28] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  29. [29] Next generation medical image interpretation with MedGemma 1.5 and medical speech to text with MedASR — reactive:deepmind-ai-co-clinician
  30. [30] Enabling a new model for healthcare with AI co-clinician — reactive:deepmind-ai-co-clinician (2026-05-01)
  31. [31] AI Collaborates with Physicians in 1M Clinical Consultations in 24 Hours | OpenEvidence posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  32. [32] AI Reshaping Clinical Decision-Making: OpenEvidence’s 2026 Strategic Outlook and Implications for the Greater Bay Area — reactive:deepmind-ai-co-clinician
  33. [33] The Clinical AI Landscape in 2026: ChatGPT, OpenEvidence, iatroX, Medwise, and What Comes Next | iatroX Clinical AI Insights — reactive:deepmind-ai-co-clinician
  34. [34] OpenEvidence Review — Clinical AI Report | Clinical AI Report — reactive:deepmind-ai-co-clinician
  35. [35] OpenEvidence revenue, valuation & funding - Sacra — reactive:deepmind-ai-co-clinician
  36. [36] How OpenEvidence AI is transforming clinical decision-making — reactive:deepmind-ai-co-clinician
  37. [37] Abridge Partners with NEJM and JAMA for AI Clinical Decision-Making — reactive:deepmind-ai-co-clinician
  38. [38] Why Abridge is Embedding NEJM and JAMA Directly into the EHR — reactive:deepmind-ai-co-clinician
  39. [39] Abridge partners with medical journals to expand AI clinical decision support | Healthcare Dive — reactive:deepmind-ai-co-clinician
  40. [40] Abridge incorporates more clinical evidence into its decision support tools | Healthcare IT News — reactive:deepmind-ai-co-clinician
  41. [41] Partnership for clinical decision support moves AI to next level — reactive:deepmind-ai-co-clinician
  42. [42] Abridge to Bring NEJM & JAMA into Clinical Conversations — reactive:deepmind-ai-co-clinician
  43. [43] Abridge Partners with NEJM and JAMA to Integrate Peer-Reviewed ... — reactive:deepmind-ai-co-clinician
  44. [44] Abridge Clinical Decision Support | Evidence Shaped by Your Conversation — reactive:deepmind-ai-co-clinician
  45. [45] Will 2026 be the year of real-world evidence that #AI can actually ... — reactive:deepmind-ai-co-clinician
  46. [46] AMA: Physicians' use of AI doubled from 2023 to 2026 — reactive:deepmind-ai-co-clinician
  47. [47] [PDF] 2026 Physician Survey on Augmented Intelligence — reactive:deepmind-ai-co-clinician
  48. [48] Feb. 27, 2026: National Advocacy Update — reactive:deepmind-ai-co-clinician
  49. [49] Physician Survey on Augmented Intelligence | American Medical Association — reactive:deepmind-ai-co-clinician
  50. [50] AMA: Physicians must lead in developing AI tools to improve patient ... — reactive:deepmind-ai-co-clinician
  51. [51] More than 80% of physicians use AI professionally: AMA survey | American Medical Association — reactive:deepmind-ai-co-clinician
  52. [52] Big Tech Enters Healthcare with Amazon Health, Microsoft Copilot ... — reactive:deepmind-ai-co-clinician
  53. [53] AI Solutions Optimized for Epic | Microsoft for Healthcare — reactive:deepmind-ai-co-clinician
  54. [54] Randomized Trial Protocol: Epic Generative AI Chart Summarization Tool to Reduce Ambulatory Provider Cognitive Task Load | medRxiv — reactive:deepmind-ai-co-clinician
  55. [55] Amazon's Healthcare AI vs. Everyone Else: Who Will Own the Doctor's Office in 2026? | AI Magicx Blog | AI Magicx — reactive:deepmind-ai-co-clinician
  56. [56] Epic AI Charting 2026: What Healthcare Providers Need to Know | SOAPNoteAI - SOAP Note Guides and Examples — reactive:deepmind-ai-co-clinician
  57. [57] Amazon makes a new bet on healthcare AI, rivaling Microsoft in the doctor's office – GeekWire — reactive:deepmind-ai-co-clinician
  58. [58] Amazon Scales Health AI Assistant to All US Customers — reactive:deepmind-ai-co-clinician
  59. [59] Epic's AI Scribe: Impact on Ambient Market and Predictions | Joshua Liu posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  60. [60] FDA Approval of Artificial Intelligence and Machine Learning ... - PMC — reactive:deepmind-ai-co-clinician
  61. [61] FDA finalizes recommendations simplifying approval process for medical devices that use AI | AHA News — reactive:deepmind-ai-co-clinician
  62. [62] Artificial Intelligence in Clinical Decision-Making: Regulatory Roadmap and Reimbursement Strategies | Akin Gump Strauss Hauer & Feld LLP - JDSupra — reactive:deepmind-ai-co-clinician
  63. [63] Artificial Intelligence in Software as a Medical Device - FDA — reactive:deepmind-ai-co-clinician
  64. [64] Artificial Intelligence-Enabled Medical Devices - FDA — reactive:deepmind-ai-co-clinician
  65. [65] Considerations for the Use of Artificial Intelligence - FDA — reactive:deepmind-ai-co-clinician
  66. [66] Journal of Medical Internet Research - AI Act Compliance Within the MyHealth@EU Framework: Tutorial — reactive:deepmind-ai-co-clinician
  67. [67] European Commission consultation shapes high-risk AI classification for life sciences in the EU | Osborne Clarke — reactive:deepmind-ai-co-clinician
  68. [68] Balancing Innovation and Control: The European Union AI Act ... — reactive:deepmind-ai-co-clinician
  69. [69] The EU AI Act & Pharma: Compliance Guide + Flowchart | IntuitionLabs — reactive:deepmind-ai-co-clinician
  70. [70] EU Commission Consultation on High-Risk AI Systems — reactive:deepmind-ai-co-clinician
  71. [71] AI in Clinical Trials & Compliance with the EU AI Act — reactive:deepmind-ai-co-clinician
  72. [72] Artificial Intelligence in healthcare — reactive:deepmind-ai-co-clinician
  73. [73] Article 6: Classification Rules for High-Risk AI Systems | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  74. [74] Annex III: High-Risk AI Systems Referred to in Article 6(2) - EU AI Act — reactive:deepmind-ai-co-clinician
  75. [75] How the EU AI Act Affects Clinical Trials — reactive:deepmind-ai-co-clinician
  76. [76] EU AI Act Compliance: Annex III Extension Guide 2024 — reactive:deepmind-ai-co-clinician
  77. [77] EU AI Act for Medical Devices: SaMD Compliance ... - MDx CRO — reactive:deepmind-ai-co-clinician
  78. [78] High-Risk AI Systems Under the EU AI Act - DPO Consulting — reactive:deepmind-ai-co-clinician
  79. [79] High-Risk AI Systems: Strict Compliance Obligations You Need to ... — reactive:deepmind-ai-co-clinician
  80. [80] EU AI Act and Medical Devices: Compliance Guide 2026 — reactive:deepmind-ai-co-clinician
  81. [81] [PDF] Conformity Assessments under the EU AI Act: A step-by step guide — reactive:deepmind-ai-co-clinician
  82. [82] Implementation Timeline | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  83. [83] The Emerging Therapeutic Triad: How AI Complicates Informed ... — reactive:deepmind-ai-co-clinician
  84. [84] Artificial intelligence and the law of informed consent - Research Handbook on Health, AI and the Law - NCBI Bookshelf — reactive:deepmind-ai-co-clinician
  85. [85] The use of #AI tools in health care raises questions about patient ... — reactive:deepmind-ai-co-clinician
  86. [86] Patient Consent and The Right to Notice and Explanation of AI ... — reactive:deepmind-ai-co-clinician
  87. [87] Notification and Consent Preferences Based on U.S. National Survey — reactive:deepmind-ai-co-clinician
  88. [88] Consent All the Way Down: What Healthcare AI Disclosure Inherits from Privacy Law - CodeX - Stanford Law School — reactive:deepmind-ai-co-clinician
  89. [89] Informed Consent, Redefined: How AI and Big Data Are Changing the Rules - Petrie-Flom Center — reactive:deepmind-ai-co-clinician
  90. [90] Big week for AI: 🤖 — reactive:deepmind-ai-co-clinician (2026-05-02)
  91. [91] 🩺 Doctor + AI + Patient — reactive:deepmind-ai-co-clinician (2026-05-01)
  92. [92] Google DeepMind's AI co-clinician research is a reminder that the next healthcare AI wave may not replace doctors. It ma... — reactive:deepmind-ai-co-clinician (2026-05-01)
  93. [93] OpenAI introduces Advanced Account Security, DeepMind AI co-clinician | Next in AI | Astha La Vista #ai #artificialint... — reactive:deepmind-ai-co-clinician (2026-05-01)
  94. [94] AI News – May 1, 2026 — reactive:deepmind-ai-co-clinician (2026-05-01)
  95. [95] Google DeepMind's AI clinician aims to aid doctors | StartupHub.ai — reactive:deepmind-ai-co-clinician
  96. [96] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  97. [97] AI co-clinician: enabling a new model for healthcare | Vishnu Ravi, MD — reactive:deepmind-ai-co-clinician
  98. [98] Google DeepMind isn’t building an AI doctor — it’s giving doctors an AI teammate. — reactive:deepmind-ai-co-clinician (2026-05-01)
  99. [99] Google DeepMind chamou de "co-clinician", não de "AI doctor" ou "diagnostic agent". — reactive:deepmind-ai-co-clinician (2026-05-01)
  100. [100] Google DeepMind's AI co-clinician runs live video with patients, guides physical exams in real time, and defers to physi... — reactive:deepmind-ai-co-clinician (2026-05-01)
  101. [101] الوضع صار اكثر جديه الان وممتع 😅 — reactive:deepmind-ai-co-clinician (2026-05-01)
  102. [102] Compare AWS HealthScribe vs. Clinically AI in 2026 — reactive:deepmind-ai-co-clinician
  103. [103] 2026 AI Medical Scribe Comparison: Top Tools for Clinicians | Twofold Health posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  104. [104] Healthcare AI Platforms: AWS vs Microsoft vs Google 2026 — reactive:deepmind-ai-co-clinician
  105. [105] Top AI Medical Scribe Companies in 2026 | Accuracy & Comparison — reactive:deepmind-ai-co-clinician
  106. [106] 15 Best AI Medical Scribes in 2026 (Ranked & Compared) - DeepCura — reactive:deepmind-ai-co-clinician
  107. [107] AWS HealthScribe vs. Clinically AI Comparison - SourceForge — reactive:deepmind-ai-co-clinician
  108. [108] 9 Best AI Scribes [2026] Comparisons, Benefits, Features, and More — reactive:deepmind-ai-co-clinician
  109. [109] 5 Best AI Medical Scribe Tools for 2026: In-Depth Comparison - Reddit — reactive:deepmind-ai-co-clinician
  110. [110] Google DeepMind’s real-time video AI doctor is here. — Rohan Paul Twitter (2026-04-30)
  111. [111] 🔴 DeepMind AI co-clinician: 98 blind-eval queries — doctors preferred it. 97/98 zero critical errors. — reactive:deepmind-ai-co-clinician (2026-05-01)
  112. [112] Google to evaluate conversational AI in virtual care — reactive:deepmind-ai-co-clinician
  113. [113] Google Research Partners with Included Health on Nationwide AI ... — reactive:deepmind-ai-co-clinician
  114. [114] Understanding FDA regulations for AI in SaMD | ICON plc — reactive:deepmind-ai-co-clinician
  115. [115] FDA Clearance & Clinical Adoption for AI Diagnostics | Bot Image — reactive:deepmind-ai-co-clinician
  116. [116] AI for Medical Device Regulation (FDA): Accelerating Approval Pathways - PPLE Labs — reactive:deepmind-ai-co-clinician
  117. [117] Demystifying Regulatory Hurdles: How to Navigate FDA Approval for ... — reactive:deepmind-ai-co-clinician
  118. [118] How to Get your AI models FDA approved: AI/ML Regulatory Landscape | Encord — reactive:deepmind-ai-co-clinician
  119. [119] 66% of US doctors now use AI in your care — often without saying ... — reactive:deepmind-ai-co-clinician
  120. [120] When AI is in the room: rethinking the medical conversation | InSight+ — reactive:deepmind-ai-co-clinician
  121. [121] AI is a 'third party' in the consultation room, say experts - BMJ Group — reactive:deepmind-ai-co-clinician
  122. [122] AI co-clinician from DeepMind will start a new product war provoking OpenEvidence, DoximityGPT, ChatGPT for Clinicians, ... — reactive:deepmind-ai-co-clinician (2026-05-01)
  123. [123] Google Deepmind just announced an AI that sits in the exam room with your doctor. — reactive:deepmind-ai-co-clinician (2026-05-01)
  124. [124] 醫院 AI 不再叫「工具」，改名「聯合醫師」。 — reactive:deepmind-ai-co-clinician (2026-05-01)
  125. [125] AI assistant for doctors? Google DeepMind working on AI model that ... — reactive:deepmind-ai-co-clinician
  126. [126] MedGemma 1.5 model card | Health AI Developer Foundations — reactive:deepmind-ai-co-clinician
  127. [127] MedGemma 1.5: Mastering 3D Medical Imaging and EHR Analysis — reactive:deepmind-ai-co-clinician
  128. [128] [2604.05081] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  129. [129] (PDF) MedGemma 1.5 Technical Report - ResearchGate — reactive:deepmind-ai-co-clinician
  130. [130] MedGemma 1.5: Run Medical AI on Your Own Servers - medgemma.pro — reactive:deepmind-ai-co-clinician
  131. [131] MedGemma 1.5 Extends Google's Open Model for Healthcare AI ... — reactive:deepmind-ai-co-clinician
  132. [132] MedGemma: Advanced AI Models for Medical Text and Image ... — reactive:deepmind-ai-co-clinician
  133. [133] Revolutionizing Healthcare: How Google DeepMind is Transforming ... — reactive:deepmind-ai-co-clinician
  134. [134] Google Deepmind launches AI Co-Clinician initiative - Reddit — reactive:deepmind-ai-co-clinician
  135. [135] Wow, this is so cool! Real-time AI doctor, via video, from Google ... — reactive:deepmind-ai-co-clinician
  136. [136] Google DeepMind deklassiert mit dem AI co-clinician GPT-5.4 im Medizin-Benchmark. Ein multimodales KI-Modell für Live-Te... — reactive:deepmind-ai-co-clinician (2026-04-30)
  137. [137] @AudioBooksRU @GoogleDeepMind @harvardmed @StanfordMed You're right—the demo shows the AI co-clinician directly intervie... — reactive:deepmind-ai-co-clinician (2026-04-30)
  138. [138] AI co-clinician: researching the path toward AI-augmented care — Google DeepMind https://t.co/6qXLmCd8Av — reactive:deepmind-ai-co-clinician (2026-04-30)
  139. [139] AI co-clinician: researching the path toward AI-augmented care - Google DeepMind https://t.co/JA2TobQ7jS — reactive:deepmind-ai-co-clinician (2026-04-30)
  140. [140] This AI co-clinician from Google DeepMind aced 97 out of 98 clinical tests — reactive:deepmind-ai-co-clinician (2026-04-30)
  141. [141] Google DeepMindが『AI co-clinician』を発表。マルチモーダルエージェントが医療現場をサポート。医療従事者とAIの協働で課題解決へ。ぼくも注視中。 by トウマ — reactive:deepmind-ai-co-clinician (2026-04-30)
  142. [142] Google DeepMind、医師を支援する AI co-clinician を発表🏥🤖 臨床エビデンス統合で 98 件中 97 件を正確に処理。テレメディシンでは一次医療医と同等のパフォーマンス。WHO が指摘する医療労働者 1000 ... — reactive:deepmind-ai-co-clinician (2026-04-30)
  143. [143] Excited to see DeepMind's AI co‑clinician initiative advancing multimodal support. To deliver value on healthcare teams... — reactive:deepmind-ai-co-clinician (2026-04-30)
  144. [144] NEWS: Google DeepMind announces AI co-clinician for healthcare. — reactive:deepmind-ai-co-clinician (2026-04-30)
  145. [145] Google Deepmind dropped ai co clinician research today — reactive:deepmind-ai-co-clinician (2026-04-30)
  146. [146] Google DeepMind unveils AI co-clinician. — reactive:deepmind-ai-co-clinician (2026-04-30)
  147. [147] NEWS: Google DeepMind launches an AI co-clinician research project to explore how multimodal agents can assist healthcar... — reactive:deepmind-ai-co-clinician (2026-04-30)
  148. [148] Google DeepMind just dropped an AI co-clinician 🤖 — reactive:deepmind-ai-co-clinician (2026-04-30)
  149. [149] Google DeepMind Just Solved a Major Problem with AI Doctors — reactive:deepmind-ai-co-clinician
  150. [150] 2026年4月30日、Google DeepMindが「AI co-clinician: researching the path toward AI-augmented care」を公開しました。臨床推論や診療判断を補助するAI共同臨床医... — reactive:deepmind-ai-co-clinician (2026-04-30)
  151. [151] BREAKING: google deepmind publishes research on an ai co-clinician model for healthcare. https://t.co/8uNF4AewKw — reactive:deepmind-ai-co-clinician (2026-04-30)
  152. [152] Google DeepMind's real-time video AI doctor is here. They just ... — reactive:deepmind-ai-co-clinician
  153. [153] Google Partners with Included Health on Nationwide AI in Virtual ... — reactive:deepmind-ai-co-clinician